» Articles » PMID: 38172354

FOXM1 Transcriptional Regulation of RacGAP1 Activates the PI3K/AKT Signaling Pathway to Promote the Proliferation, Migration, and Invasion of Cervical Cancer Cells

Overview
Specialty Oncology
Date 2024 Jan 3
PMID 38172354
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cervical cancer (CC) is the most common gynecological tumor disease in women, which occurs at the junction of cervical squamous columnar epithelium. We investigated the effect and mechanism of transcription factor FOXM1 synergizing RacGAP1 in the proliferation, migration, and invasion of CC cells.

Methods: Here, we analyzed the correlation between FOXM1 and RacGAP1 and the clinicopathological features of 68 CC patients. RT-qPCR was used to assess FOXM1 and RacGAP1 mRNA expression in CC tissues and cells. Cell proliferation was assessed by CCK-8 and EDU assays. Transwell assay was applied to test migration and invasion. Cell apoptosis was evaluated utilizing flow cytometry. ChIP and dual-luciferase reporter assays confirmed the interaction of FOXM1 and RacGAP1. Protein levels of FOXM1 and RacGAP1, as well as PI3K/AKT, were analyzed by Western blot.

Results: FOXM1 expression was correlated with FIGO stage and histological grade, and RacGAP1 expression was correlated with histological grade. FOXM1 and RacGAP1 levels were increased in CC tissues, and higher expressed in human CC cell lines than that in an immortalized HPV-negative skin keratinocyte line (HaCaT). Depleted RacGAP1 suppressed CC cell proliferation, migration and invasion, and promoted apoptosis. RacGAP1 was a target gene of FOXM1, and FOXM1 positively regulated RacGAP1 expression. FOXM1 had a synergistic effect with RacGAP1 to exert oncogenic function in CC by activating the PI3K/AKT signaling.

Conclusion: FOXM1 cooperates with RacGAP1 to induce CC cell proliferation, migration and invasion, inhibit apoptosis, and regulate PI3K/AKT signaling to promote CC progression.

Citing Articles

The Expression Regulation and Cancer-Promoting Roles of RACGAP1.

Lin J, Zhu Y, Lin Z, Yu J, Lin X, Lai W Biomolecules. 2025; 15(1).

PMID: 39858398 PMC: 11760467. DOI: 10.3390/biom15010003.


BTF3 affects hepatocellular carcinoma progression by transcriptionally upregulating PDCD2L and inactivating p53 signaling.

Kong M, Shi X, Gao J, Guo W Mol Med. 2024; 30(1):252.

PMID: 39707202 PMC: 11660624. DOI: 10.1186/s10020-024-01044-x.


Human Papillomavirus-Associated Giant Clear Cell Acanthoma and Squamous Cell Carcinoma: A Rare Case Report and Literature Review.

Cuomo R, Rozen W, Pentangelo P, Ceccaroni A, Alfano C, Seth I J Clin Med. 2024; 13(9).

PMID: 38731009 PMC: 11084788. DOI: 10.3390/jcm13092482.

References
1.
Johnson C, James D, Marzan A, Armaos M . Cervical Cancer: An Overview of Pathophysiology and Management. Semin Oncol Nurs. 2019; 35(2):166-174. DOI: 10.1016/j.soncn.2019.02.003. View

2.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

3.
Hu Z, Ma D . The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018; 7(10):5217-5236. PMC: 6198240. DOI: 10.1002/cam4.1501. View

4.
Olusola P, Banerjee H, Philley J, Dasgupta S . Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. Cells. 2019; 8(6). PMC: 6628030. DOI: 10.3390/cells8060622. View

5.
Eid R, Soltan M, Eldeen M, Shati A, Dawood S, Eissa M . Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. Int J Mol Sci. 2022; 23(22). PMC: 9695706. DOI: 10.3390/ijms232214102. View